MIR2861

gene
On this page

Also known as hsa-mir-2861

Summary

MIR2861 (microRNA 2861, HGNC:38221) is a microRNA gene on chromosome 9q34.11.

microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of target mRNAs. This microRNA may play a role in osteoblast differentiation and a mutation in this gene is associated with osteoporosis. Altered expression of this microRNA has been observed in human cancers, with reduced expression seen in cervical cancer, while expression in papillary thyroid carcinoma (PTC) is increased.

Source: NCBI Gene 100422910 — RefSeq curated summary.

At a glance

  • Gene type: non-coding (miRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:38221
Approved symbolMIR2861
NamemicroRNA 2861
Location9q34.11
Locus typeRNA, micro
StatusApproved
Aliaseshsa-mir-2861
Ensembl geneENSG00000284547
Ensembl biotypemiRNA
OMIM613405
Entrez100422910
RNAcentralURS000075ADBF — miRNA, 90 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 miRNA

ENST00000636310

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000636310 — 1 exons

ExonStartEnd
ENSE00003798722127785918127786007

Expression profiles

Bgee: expression breadth broad, 64 present calls, max score 78.79.

Top tissues by expression

64 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
vermiform appendixUBERON:000115478.79gold quality
placentaUBERON:000198775.12gold quality
bloodUBERON:000017872.62gold quality
heart left ventricleUBERON:000208471.58gold quality
gastrocnemiusUBERON:000138870.07gold quality
body of pancreasUBERON:000115069.46gold quality
body of stomachUBERON:000116169.25gold quality
right atrium auricular regionUBERON:000663168.59gold quality
heartUBERON:000094868.09gold quality
right adrenal glandUBERON:000123366.43gold quality
small intestineUBERON:000210864.88gold quality
tibial arteryUBERON:000761063.46gold quality
small intestine Peyer’s patchUBERON:000345462.72gold quality
substantia nigraUBERON:000203862.58gold quality
colonUBERON:000115562.55gold quality
adult mammalian kidneyUBERON:000008262.23gold quality
skin of legUBERON:000151161.40gold quality
minor salivary glandUBERON:000183061.30gold quality
esophagus mucosaUBERON:000246961.24gold quality
body of uterusUBERON:000985361.24gold quality
skeletal muscle tissueUBERON:000113460.93gold quality
transverse colonUBERON:000115760.92gold quality
left coronary arteryUBERON:000162660.86gold quality
upper lobe of left lungUBERON:000895260.67gold quality
Ammon’s hornUBERON:000195460.65gold quality
esophagogastric junction muscularis propriaUBERON:003584160.60gold quality
left adrenal glandUBERON:000123460.55gold quality
amygdalaUBERON:000187660.51gold quality
muscle layer of sigmoid colonUBERON:003580560.44gold quality
C1 segment of cervical spinal cordUBERON:000646960.01gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.00

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 9)

  • a homozygous mutation in pre-miR-2861 that blocked expression of miR-2861, targeting HDAC5, was shown to cause primary osteoporosis in 2 related adolescents (PMID:19920351)
  • Investigated miRNA deregulation in papillary thyroid carcinoma, particularly with lymph node (LN) metastasis. Expression of either miR-2861 or miR-451 in the LN group was significantly greater than that in the NLN group. (PMID:23609190)
  • we have established a serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) that could distinguish CC from CIN and healthy controls with high accuracy. (PMID:26656154)
  • the overexpression of miR-2861 and RUNX2 in human Periodontal Ligament Stem Cells cultured in presence of 3D Endobon Xenograft granule scaffold under osteogenic and standard conditions was demonstrated (PMID:28078846)
  • Further origin identification revealed that the expression levels of miR-122 in CECs and lymphocytes, miR-140-3p and -2861 in monocytes and CECs, miR-720 in monocytes, and miR-3149 in CECs were greatly up-regulated in the ACS patients compared with the non-ACS patients (PMID:28961259)
  • miR-2861 expression was significantly higher in lung cancer stem cells (LCSCs) no matter compared to the differentiation cells or normal cells. HDAC5 expression was positively correlated with miR-2861 in LCSCs, and knockdown of miR-2861 decreased the expression of HDAC5, which implied that HDAC5 may be involved in the differentiation of LCSCs mediated by miR-2861. (PMID:29620443)
  • Our study reveals that miR-2861 was lowly expressed in endometriotic tissues, and downregulation of miR-2861 may promote proliferation and inhibit apoptosis of ectopic endometrial cells in endometriosis via upregulation of STAT3 and MMP2. (PMID:30940310)
  • SNHG14 induces osteogenic differentiation of human stromal (mesenchymal) stem cells in vitro by downregulating miR-2861. (PMID:32770994)
  • LncRNA MIR22HG is downregulated in adenomyosis and upregulates miR-2861 through demethylation to inhibit endometrial cell proliferation. (PMID:33624428)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.